Notice
3 Jul 2025
regulatory compliance, technology, fda, ai, drug safety, pharma
💊FDA Seeks Comments on Drug Safety Technology Meeting Program
The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the Emerging Drug Safety Technology Meeting (EDSTM) Program.
Learn More